{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Dr. Reddy\u2019s Q4 &amp; FY23 Financial Results - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"he5aPRDnac\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-q4-fy23-financial-results\/\">Dr. Reddy\u2019s Q4 &amp; FY23 Financial Results<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-q4-fy23-financial-results\/embed\/#?secret=he5aPRDnac\" width=\"600\" height=\"338\" title=\"&#8220;Dr. Reddy\u2019s Q4 &amp; FY23 Financial Results&#8221; &#8212; Market Newsdesk\" data-secret=\"he5aPRDnac\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Dr. Reddy\u2019s Q4 &amp; FY23 Financial Results HYDERABAD, India&#8211;(BUSINESS WIRE)&#8211; Dr. Reddy\u2019s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for the fourth quarter and full year ended March 31, 2023. The information mentioned in this release is on the basis of consolidated financial statements under International Financial Reporting Standards (IFRS). This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230510005650\/en\/ Q4 FY23 Sales Mix (Graphic: Business Wire) Q4 Performance Summary FY23 Performance Summary \u00a0 Rs. 6,297 Cr Rs. 24,588 Cr Revenue Revenue [Up: 16% YoY; Down 7% QoQ] [Up: 15% YoY] \u00a0 57.2% 56.7% Gross Margin Gross Margin [Q4 FY22: 52.9%; Q3 FY23: 59.2%] [FY22: 53.1%] \u00a0 &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/mms.businesswire.com\/media\/20230510005650\/en\/1789642\/4\/1.jpg"}